Improvement of PnPP-19 peptide bioavailability for glaucoma therapy: Design and application of nanowafers based on PVA-Reference-Cited by-同舟云学术

Improvement of PnPP-19 peptide bioavailability for glaucoma therapy: Design and application of nanowafers based on PVA

Published:2022-08 Issue: Volume:74 Page:103501
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Dourado Lays Fernanda Nunes^ORCID,Silva Carolina Nunes da^ORCID,Gonçalves Rafael Silva^ORCID,Inoue Thomas Toshio,de Lima Maria Elena^ORCID,Cunha-Júnior Armando da Silva

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Instituto Nacional de Ciência e Tecnologia da Criosfera

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Instituto Nacional de Ciência e Tecnologia para Excitotoxicidade e Neuroproteção

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference38 articles.

1. Topical drug delivery devices: a review;Bertens;Exp. Eye Res.,2018

2. Challenges and obstacles of ocular pharmacokinetics and drug delivery;Urtti;Adv. Drug Deliv. Rev.,2006

3. Ocular novel drug delivery: impacts of membranes and barriers;Barar;Expet Opin. Drug Deliv.,2008

4. Sistemas de transporte de drogas para o segmento posterior do olho: bases fundamentais e aplicações;Fialho;Arq. Bras. Oftalmol.,2007

5. Topical and systemic drug delivery to the posterior segments;Hughes;Adv. Drug Deliv. Rev.,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomedical applications of synthetic peptides derived from venom of animal origin: A systematic review;Biomedicine & Pharmacotherapy;2024-01

2. An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye;ACS Omega;2023-09-22

3. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects;Journal of Nanobiotechnology;2023-07-22

4. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases;Journal of Controlled Release;2023-02